Process for the manufacture of piperazinopyrrolobenzodiazepines
CA 1113934 A · Owner: Novartis Pharmaceuticals Canada Inc./Novartis Pharma Canada Inc. · Inventors: Wasley, Jan W.F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns the manufacture of new 1,3,4,14b-tetrahydro-2H,1OH-pyrazino1,2-alpyrrolo2,1-c 1,4lbenzodlazeplnes of the formula, (I) wherein each of R1, R3 and R4 is hydrogen or lower alkyl; R2 is hydrogen, lower or higher alkyl, lower alkenyl lower, alkynyl, or (3 to 7 ring-membered cycloalkyl hydroxy, carboxy, lower carbalkoxy, carbamoyl HPh, lower alkanoyl, or HPhCO)-lower alkyl; Ph is 1,2-phenylene unsubstituted, or substituted by up to two members selected from lower alkyl, lower alkoxy, halogeno and trifluormethyl; CnH2n is lower alkylene separating both nitrogen atoms by 2 or 3 carbon atoms and R5 is hydrogen, lower alkyl lower carb-, alkoxy or hydroxy-lower alkyl; the lower …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted December 8, 1981. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended December 8, 1998.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.